MedPath

Transdiagnotic internet-based and mobile-supported intervention for the treatment of depressio

Not Applicable
Conditions
F32
F41.9
F41.1
F40
Depressive episode
Anxiety disorder, unspecified
Generalized anxiety disorder
Phobic anxiety disorders
Registration Number
DRKS00011690
Lead Sponsor
Friedrich-Alexander Universität Erlangen-Nürnberg, Lehrstuhl für Klinische Psychologie und Psychotherapie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Minimum age 18; Signed consent form; Clinical diagnosis of depression determined by diagnostic interview

Exclusion Criteria

Acute suicidal tendency determined by initial diagnostic interview; unwilling to sign the consent form; psychotherapeutical treatment in the last 6 months or on waiting list for psychotherapy; self-report on present psychosis or dissociative symptoms; bipolar disorder in the past or present

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptom severity of depression at time of post-measurement determined by: <br>• Diagnostic interview (QIDS-C, Rush, Trivedi, Ibrahim, Carmody, Arnow, et al., 2003), time of measurement at Baseline (t1), Post (t2) and 6 months follow-up (t3) <br>• Self-report (CES-D, Radloff, 1977; PHQ-9, Kroenke, Spitzer, Williams, 2001), CES-D on a weekly Basis (week 1 - 7), at t0, t1, t2, t3; PHQ at t1, t2, t3<br>t0 = Screening, before study inclusion<br>t1 = Baseline<br>t2 = Posttreatment (after completion of module 7 or after 8 weeks)<br>t3 = 6-month follow-up<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath